The following are possible outcomes and benefits for individuals using tesofensine: Decrease in body weight and reduction in BMI Improvements in waist and hip circumference Decreased body fat Decreased visceral fat Decreased very-low-density lipoprotein & triglycerides Decreased insulin Better regulation of glucose metabolism Potential of reversing early type 2 diabetes In general, tesofensine is very well tolerated with few adverse effects and very similar to placebo
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Standard protocols use 0.25-0.5 mg (250-500 mcg) daily via subcutaneous injection
The peptides ability to repair and regenerate cartilage can provide relief for those suffering from joint pain and osteoarthritis
Following your healthcare provider's schedule is key
Intracellular Activity: Unlike -MSH, which acts extracellularly, KPV enters cells and directly inhibits inflammatory signaling molecules within the nucleus
